MIRA Pharmaceuticals grants director 50,000 stock options
MIRA PHARMACEUTICALS, INC. reported that director Shekhat Denil Nanji received a grant of stock options to buy 50,000 shares of common stock at an exercise price of $0.94 per share on June 12, 2026.
Rhea-AI Filing Summary
MIRA PHARMACEUTICALS, INC. reported that director Shekhat Denil Nanji received a grant of stock options to buy 50,000 shares of common stock at an exercise price of $0.94 per share on June 12, 2026. The options were granted under the company’s 2022 Omnibus Incentive Plan as compensation, not as an open‑market purchase.
According to the grant terms, 50% of the options vest six months after the grant date and the remaining 50% vest one year after the grant date. The options expire on June 12, 2036 if not exercised. After this award, Nanji holds 50,000 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
Shekhat Denil Nanji
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (right to buy) — 50,000 contracts (Direct)
Footnotes (3)
- F1. The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.
- F2. The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.
- F3. Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.
Key Figures
Option grant size: 50,000 options
Exercise price: $0.94 per share
Post-grant derivative holdings: 50,000 options
+3 more
6 metrics
Option grant size
50,000 options
Stock options granted on June 12, 2026
Exercise price
$0.94 per share
Exercise price of granted stock options
Post-grant derivative holdings
50,000 options
Total options held following the transaction
Option term
Expires June 12, 2036
Expiration date of the granted options
Initial vesting
50% at six months
First tranche vests six months after grant date
Final vesting
50% at one year
Second tranche vests one year after grant date
Key Terms
Stock Options, exercise price, 2022 Omnibus Incentive Plan, vesting
4 terms
Stock Options financial
"Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"at an exercise price of $0.94 each"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
2022 Omnibus Incentive Plan financial
"pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated"
vesting financial
"50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MIRA (MIRA) report for Shekhat Denil Nanji?
MIRA reported that director Shekhat Denil Nanji received a grant of 50,000 stock options on June 12, 2026. These options are compensation awards, not open-market purchases or sales, and give the right to buy common shares at a fixed exercise price.
How many stock options were granted to the MIRA (MIRA) director and at what price?
The director received 50,000 stock options with an exercise price of $0.94 per share. This means Nanji can purchase up to 50,000 MIRA common shares at $0.94, regardless of the future market price, once the options vest and before expiration.
What is the vesting schedule for the 50,000 MIRA (MIRA) stock options?
The 50,000 stock options vest in two equal tranches. Half of the options vest six months after the June 12, 2026 grant date, and the remaining half vest one year after the grant date, assuming continued service under the company’s incentive plan.
When do the newly granted MIRA (MIRA) stock options expire?
The granted stock options expire on June 12, 2036, giving a 10-year term from the grant date. Nanji must exercise any vested options before that expiration date or they will lapse and no longer be exercisable for MIRA common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
